As we’ve mentioned, valuation professionals, accountants and investment banks have become increasingly focused on trained on the valuation of cannabis companies and assets, with EY preparing their insights on cannabis valuations here. This piece addresses regulatory and transactional developments
Rolnick Kramer Sadighi LLP
Rolnick Kramer Sadighi LLP is a law firm specializing in strategic litigation solutions for the investment management sector. The firm focuses on complex legal issues including securities opt-out and structured finance litigation, creditor and debtholder rights, valuation litigation, shareholder rights, mergers and acquisitions, and activist litigation. Its publications often analyze case law developments, statutory interpretations, and practical implications of appraisal rights and valuation methodologies, particularly in Delaware and other jurisdictions. The firm provides insights into legal strategies and evolving jurisprudence affecting minority shareholder protections, merger valuations, and litigation tactics within corporate and financial contexts. Its content is aimed at legal professionals and stakeholders involved in investment management and corporate litigation.
Latest from Rolnick Kramer Sadighi LLP - Page 8
Appraisal Action Leads to Insurance Action: D&O Doesn’t Cover Appraisal
The Delaware Supreme Court has had its say on whether Directors and Officers insurance policies that covered claims for “actual or alleged” violation “of any federal, state or local statute, regulation or rule or common law regulating securities” covered appraisal…
Cannabis Business Valuation: White Paper Update
Further to our prior post on FTI’s cannabis valuation primer, FTI has now published an update addressing developments resulting from Canada’s legalization of the production and sale of edible cannabis, cannabis extracts and cannabis topics, as well as the slower-than-expected…
Cannabis Business Valuation: FTI White Paper
The valuation of companies in the ever-growing cannabis space has become an increasing area of focus within this valuation sphere. Cannabis presents a highly unique valuation landscape given the regulatory environment, increasing popular acceptance of recreational as well as medical…
Books and Records (Del.): Valuing Private Shares is a Proper Purpose
Shareholder rights (at least in Delaware) include the right to inspect the books and records of the company for a “proper purpose”. What is a proper purpose? We’ll be covering a number of cases in the coming months on this…
Amerisource Bergen Goes to Del. Supreme Court Over Shareholders’ Access to Books and Records
AmerisourceBergen Corp. has asked the Delaware Supreme Court to reverse a Chancery Court ruling allowing shareholders the right to investigate the company’s books and records for corporate wrongdoing in connection with the opioid crisis. Amerisource Bergen argued before the full…
SEC Enacts Stricter Rules for Shareholder Proposals
The SEC has recently enacted rules that make it tougher for shareholders to submit ballot proposals. As we previously blogged about, the rules now approved by the SEC by a 3-2 vote: (1) increase the monetary amounts and length of…
New Firm, New Name, New Scope, New Look
As our securities litigation practice group has spun off from our prior firm and formed our own new shop, we are excited to announce that The Appraisal Rights Litigation Blog we created years ago has now become the Valuation Litigation…
JPMorgan Asset Management: Vote FOR Appraisal
JPMorgan Asset Management released their 2020 proxy guidelines in April, and, like many other investors we have covered, the guidelines support appraisal rights. JPMorgan Asset Management’s guidelines even lay out the value of appraisal rights in a short sentence,…
New Research: Do Managers of a Target Corporation Withhold Good News?
Does increased appraisal risk have an effect on manager behavior? Recent research (unpublished) suggests it does.
In this paper (earlier version), the author examines target manager disclosure behavior before and after the significant Transkaryotic decision. Reviewing mergers before and after…